About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | N-acetylcysteine Effects on Tetrahydrocannabinol

N-acetylcysteine Effects on Tetrahydrocannabinol

NCT02335060·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

Age

18–55

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Exposed to Cannabis at least once in lifetime

You may not be if

Cannabis Naive
Individuals with a documented allergy to N-acetylcysteine

The record

StatusTerminated

PhaseEarly phase 1

Taking part5

StartedMay 2014

UpdatedJan 31, 2022

Conditions

Where1

VA Connecticut Healthcare System
West Haven, Connecticut, United States